Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.29 +0.02 (+7.41%)
At close: Aug 20, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Acquisitions (2022 - 2026)

Scinai Immunotherapeutics (SCNI) posted Acquisitions of $2.8 million for Q1 2026, up 9586.21% sequentially from -$29000.0 in Q2 2025, and up 170.24% YoY from $1.0 million in Q1 2025.

Scinai Immunotherapeutics (SCNI) Acquisitions (2022 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Acquisitions for 5 years, with the latest figure at $2.8 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -
10 Scinai Immunotherapeutics 1.08 Mn -3.11 Bn -1.12 Mn 2.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.75 Mn
Jun 30, 2025 -29,000.00
Mar 31, 2025 1.02 Mn
Sep 30, 2024 -2.04 Mn
Jun 30, 2024 -1.75 Mn
Mar 31, 2024 4.83 Mn
Sep 30, 2023 -1.14 Mn
Jun 30, 2023 -3.29 Mn
Mar 31, 2023 10.80 Mn
Sep 30, 2022 -2.98 Mn